Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Löst diese riesige Entdeckung die Kupferkrise der KI? So ändert sich die Rechnung durch diesen Explorer!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PBSB | ISIN: SE0012141687 | Ticker-Symbol: 3AJ
Frankfurt
15.01.25
15:34 Uhr
14,120 Euro
+0,520
+3,82 %
Branche
Hotels/Tourismus
Aktienmarkt
Sonstige
1-Jahres-Chart
SKISTAR AB Chart 1 Jahr
5-Tage-Chart
SKISTAR AB 5-Tage-Chart
RealtimeGeldBriefZeit
14,00014,22019:53
GlobeNewswire (Europe)
75 Leser
Artikel bewerten:
(0)

Bulletin from Annual General Meeting of SkiStar AB

Finanznachrichten News

At SkiStar AB (publ)'s annual general meeting, held in Sälen on 14 December 2024, the following decisions were made.

  • A dividend of SEK 2.80 per share was adopted. Record day 17 December 2024.
  • Lena Apler, Fredrik Paulsson, Gunilla Rudebjer, Anders Sundström, Anders Svensson and Carina Åkerström were re-elected to the board and Bent Oustad was elected as new board member.
  • Anders Sundström was re-elected chairman of the board.
  • Board fees, including committee fees, were raised to a total of SEK 2,990,000 (2023: SEK 2,890,000). The fees shall be distributed as follows: SEK 695,000 (670,000) to the chairman of the board and SEK 322,000 (310,000) each to the other non-executive directors. Audit committee members will receive total fees of SEK 248,000 (240,000), distributed as follows: SEK 124,000 (120,000) to the committee chairman and SEK 62,000 (60,000) to each of the other two members. Remuneration committee members will receive total fees of SEK 124,000 (120,000), distributed as follows: SEK 62,000 (60,000) to the chairman and SEK 31,000 (30,000) to each of the other two members.
  • The parent company income statement and balance sheet, and consolidated income statement and balance sheet for the 2023/24 financial year were adopted.
  • Board members and the CEO were discharged from liability for the 2023/24 financial year.
  • Deloitte AB was re-elected as auditor for a period of one year. Kent Åkerlund remains chief auditor. Auditor's fees are paid on an approved current account basis.
  • The board of directors' remuneration report for 2023/24 and guidelines for remuneration to senior management were approved.
  • The board was authorized to decide on issues of new class B shares with or without deviation from shareholders' preferential rights. Decision pursuant to the authorisation may not result in a new issuance of shares exceeding ten (10) percent of all shares in the company at the time of the AGM's decision on the authorisation.
  • The board was authorized to make decisions on the purchase and transfer of the company's own shares on one or more occasions before the next AGM. Purchases must be conducted in a regulated market or in accordance with a purchase offer. The repurchases and sale of own shares only applies to class B shares.

All AGM resolutions were made in accordance with the proposals that were made available to shareholders prior to the AGM. For detailed information of the contents of the decisions, please see the complete proposals which are available at the company's webpage https://investor.skistar.com/en.

This information was submitted for publication, through the agency of the contact persons set out below, on 14 December 2024, at 4.00 p.m. CET.

Further information can be reached from:
Stefan Sjöstrand, CEO, tel +46 (0)280 841 60.
Martin Almgren, CFO, tel +46 (0)280 841 60.

SkiStar in brief
SkiStar AB (publ) is listed on the Mid Cap list of the Nasdaq Stockholm exchange. The Group owns and operates mountain resorts in Sälen, Vemdalen, Åre and Stockholm (Hammarbybacken) in Sweden, and in Hemsedal and Trysil in Norway. Operations are divided into three segments: Operation of Mountain Resorts, Property Development & Exploitation and Operation of Hotels. As the leading holiday tour operator for Scandinavia, SkiStar's business concept is to create memorable mountain experiences, develop sustainable destinations, offer accommodation, activities, products and services of the highest quality with our guests in focus. For further information, please visit https://investor.skistar.com/en.


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.